FTX-6746
FTX-6746 is a selective, orally bioavailable reverse agonist of PPARG with demonstrated anticancer properties. It has shown research utility in models of urothelial carcinoma, exhibiting activity in both in vitro cellular assays and in vivo tumor studies.
Product Specifications
CAS Number
2829349-96-2
Product Name Alternative
FTX6746, FX 909, FX909
Field of Research
Metabolism Research, Molecular Biology
Purity
98.68% (May vary between batches)
Solubility
DMSO:30 mg/mL (94.73 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (6.32 mM)
Smiles
N#CC=1C=CC (Cl) =C (C1) C2=CC (=O) C=3C (F) =CC (F) =CC3N2
Molecular Formula
C16H7ClF2N2O
Molecular Weight
316.69
Storage Conditions
-20°C
Notes
For research use only.
More Discoveries
Explore Other Products
Browse additional items from our catalog
RC206805L4 10 µg
MRPP3 (KIAA0391) (NM_014672) Human Tagged Lenti ORF Clone
Sign In for Pricing
View Details RC213607L4V 200 µL
Asialoglycoprotein Receptor 2 (ASGR2) (NM_001181) Human Tagged ORF Clone Lentiviral Particle
Sign In for Pricing
View Details 
MBS9247576-01 0.1 mg
Anti-STEAP1 Reference Antibody (vandortuzumAb)
Sign In for Pricing
View Details